Researchers Present Updated Discussion of Avian Flu
Because H5N1 influenza A viruses have the potential to cause a worldwide pandemic with mortality rates as high as 60 percent, the development of broadly protective vaccines is imperative, according to a seminar published in the April 26 issue of The Lancet.
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Related Content
Andrew Alexis, MD, MPH, highlights positive lebrikizumab-lbkz data for atopic dermatitis
June 25th 2025Article
Lebrikizumab demonstrated efficacy and safety in patients with skin of color and moderate-to-severe atopic dermatitis in the ADmirable trial. Trial investigator Andrew Alexis, MD, MPH, reacts.
